Aptose Biosciences
APTO
#10464
Rank
โ‚ฌ3.74 M
Marketcap
1,47ย โ‚ฌ
Share price
0.00%
Change (1 day)
676.07%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -โ‚ฌ19.25 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.67 Million, an increase over its 2023 earnings that were of -โ‚ฌ44.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ19.25 Million-11.16%
2024 -โ‚ฌ21.67 Million-51.82%
2023 -โ‚ฌ44.98 Million22.9%
2022 -โ‚ฌ36.6 Million-34.91%
2021 -โ‚ฌ56.23 Million17.36%
2020 -โ‚ฌ47.92 Million107.65%
2019 -โ‚ฌ23.08 Million-7.73%
2018 -โ‚ฌ25.01 Million160.68%
2017 -โ‚ฌ9.6 Million-20.27%
2016 -โ‚ฌ12.04 Million28.71%
2015 -โ‚ฌ9.35 Million
2013 -โ‚ฌ5.3 Million
2010 -โ‚ฌ4.52 Million-8.31%
2009 -โ‚ฌ4.93 Million
2006 -โ‚ฌ9.13 Million-156.93%
2005 โ‚ฌ16.02 M-185.16%
2004 -โ‚ฌ18.83 Million458.58%
2003 -โ‚ฌ3.37 Million-63.66%
2002 -โ‚ฌ9.28 Million-8.04%
2001 -โ‚ฌ10.09 Million16.73%
2000 -โ‚ฌ8.64 Million294.99%
1999 -โ‚ฌ2.19 Million-6.51%
1998 -โ‚ฌ2.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-โ‚ฌ29.23 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-โ‚ฌ49.47 Million 175.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-โ‚ฌ53.94 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA